Liu et al. [53] demonstrated the role of miR-375 in CRC, they illustrated that miR-375, a direct target of SNHG17, could reverse the inhibitory effect of SNHG17 knockdown on EMT progression by targeting CBX3. The gene discussed is SNHG17; the disease is colorectal carcinoma.